{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:10:33Z","timestamp":1768374633261,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-025-01185-7","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:24:44Z","timestamp":1765175084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coverage evaluation of mass drug administration for lymphatic filariasis in four endemic districts of Jharkhand, India"],"prefix":"10.1186","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7609-6446","authenticated-orcid":false,"given":"Bijit","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jahnavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"1185_CR1","unstructured":"Lymphatic filariasis. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lymphatic-filariasis. Accessed 27 June 2025."},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/trstmh\/trac119","volume":"117","author":"DA Ngunyali","year":"2023","unstructured":"Ngunyali DA, Mpomele SS, Kilonzi M, Mutagonda RF, Mikomangwa WP, Mlyuka HJ, et al. Knowledge and participation in mass drug administration against lymphatic filariasis and soil-transmitted helminth infections among the community members in Dar Es Salaam, Tanzania. Trans R Soc Trop Med Hyg. 2023;117:358\u201364. https:\/\/doi.org\/10.1093\/trstmh\/trac119.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/0972-9062.374034","volume":"60","author":"A Bashar","year":"2023","unstructured":"Bashar A, Nandekar SV, Shrivastava P, Singh RN, Srikrishnan P. Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of Eastern Uttar Pradesh, India. J Vector Borne Dis. 2023;60:307\u201316. https:\/\/doi.org\/10.4103\/0972-9062.374034.","journal-title":"J Vector Borne Dis"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"k5198","DOI":"10.1136\/bmj.k5198","volume":"364","author":"S Specht","year":"2019","unstructured":"Specht S, Suma TK, Pedrique B, Hoerauf A. Elimination of lymphatic filariasis in South East Asia. BMJ. 2019;364:k5198. https:\/\/doi.org\/10.1136\/bmj.k5198.","journal-title":"BMJ"},{"key":"1185_CR5","unstructured":"Revised. Guideline on Elimination of Lymphatic Filariasis. 2024."},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/j.lansea.2024.100400","volume":"25","author":"S Joy","year":"2024","unstructured":"Joy S, Rahi M. Empowering lymphatic filariasis affected individuals in india: acknowledging disability status and ensuring justice. Lancet Reg Health - Southeast Asia. 2024;25:100400. https:\/\/doi.org\/10.1016\/j.lansea.2024.100400.","journal-title":"Lancet Reg Health - Southeast Asia"},{"key":"1185_CR7","unstructured":"List. of Statewise LF Endemic Districts. 2024."},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"e0292723","DOI":"10.1371\/journal.pone.0292723","volume":"18","author":"O Dutta","year":"2023","unstructured":"Dutta O, Prasanth A, Kumari A, Akanksha K, Deeba F, Salam N. Burden of dengue, leishmaniasis and lymphatic filariasis in India and its States from 1990\u20132019: analysis from the global burden of disease study (GBD 2019). PLoS ONE. 2023;18:e0292723. https:\/\/doi.org\/10.1371\/journal.pone.0292723.","journal-title":"PLoS ONE"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/ijph.ijph_1030_23","volume":"67","author":"S Pati","year":"2023","unstructured":"Pati S. Eliminating lymphatic filariasis: india\u2019s bold plan to finish 3 years ahead of global schedule. Indian J Public Health. 2023;67:345. https:\/\/doi.org\/10.4103\/ijph.ijph_1030_23.","journal-title":"Indian J Public Health"},{"key":"1185_CR10","unstructured":"Elimination of Lymphatic Filariasis: National Center for Vector Borne Diseases Control (NCVBDC). 2024. https:\/\/ncvbdc.mohfw.gov.in. Accessed 30 June 2024."},{"key":"1185_CR11","unstructured":"Accelerated. Plan for Elimination of Lymphatic Filariasis. 2018."},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.4103\/jfmpc.jfmpc_503_19","volume":"8","author":"S Banerjee","year":"2019","unstructured":"Banerjee S, Bandyopadhyay K, Khan MF, Akkilagunta S, Selvaraj K, Tripathy JP, et al. Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, central india: A mixed method study. J Family Med Prim Care. 2019;8:3009\u201314. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_503_19.","journal-title":"J Family Med Prim Care"},{"key":"1185_CR13","unstructured":"Ministry of Health & Family Welfare launches nationwide Sarva Dawa Sevan or Mass Drug Administration (MDA) campaign to Eliminate Lymphatic Filariasis (LF). 2024. https:\/\/pib.gov.in\/pib.gov.in\/Pressreleaseshare.aspx?PRID=1898092. Accessed 30 June 2025."},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.24321\/0019.5138.202424","volume":"56","author":"SS Singh","year":"2024","unstructured":"Singh SS, Manhas AS, Yadav GK, Sharma S, Srivastava P. Community perception for mass drug Admin-istration towards elimination of lymphatic Fil-ariasis: A study in Jharkhand. JCD. 2024;56:184\u201391. https:\/\/doi.org\/10.24321\/0019.5138.202424.","journal-title":"JCD"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/jfmpc.jfmpc_1149_22","volume":"12","author":"D Kumar","year":"2023","unstructured":"Kumar D, Kumar A, Vikas K, Kumar C, Sircar S. Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India. J Family Med Prim Care. 2023;12:111\u20136. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1149_22.","journal-title":"J Family Med Prim Care"},{"key":"1185_CR16","first-page":"9","volume":"5","author":"S Haider","year":"2014","unstructured":"Haider S, Karir S, Sunderam S, Kashyap V, Singh S. Trend of MDA coverage and compliance in the four endemic districts of jharkhand: A secondary data analysis. Healthline. 2014;5:9\u201313.","journal-title":"Healthline"},{"key":"1185_CR17","unstructured":"Blocks. and Circles | District Deoghar, Government of Jharkhand | India. 2025. https:\/\/deoghar.nic.in\/blocks-and-circles\/. Accessed 26 June 2025."},{"key":"1185_CR18","unstructured":"Blocks. and Circles | District Giridih, Government of Jharkhand | India. 2025. https:\/\/giridih.nic.in\/blocks-and-circles\/. Accessed 26 June 2025."},{"key":"1185_CR19","unstructured":"Subdivision. & Blocks | District Dumka, Government of Jharkhand | India. https:\/\/dumka.nic.in\/subdivision-blocks\/. Accessed 13 July 2025."},{"key":"1185_CR20","unstructured":"Subdivision & Blocks | Godda | India. 2024. https:\/\/godda.nic.in\/subdivision-blocks\/. Accessed 26 June 2025."},{"key":"1185_CR21","unstructured":"OpenEpi - Toolkit Shell for Developing New Applications. https:\/\/www.openepi.com\/Random\/Random.htm. Accessed 13 July 2025."},{"key":"1185_CR22","unstructured":"Villages in India, India Village Finder. Maps of India. 2024. https:\/\/www.mapsofindia.com\/villages\/. Accessed 27 June 2024."},{"key":"1185_CR23","unstructured":"Guideline. \u2013 Alternative mass drug administration regimens to eliminate lymphatic filariasis. 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241550161. Accessed 2 July 2025."},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/trstmh\/tru204","volume":"109","author":"NDE Alexander","year":"2015","unstructured":"Alexander NDE. Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination. Trans R Soc Trop Med Hyg. 2015;109:173\u20134. https:\/\/doi.org\/10.1093\/trstmh\/tru204.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1185_CR25","unstructured":"jamovi desktop - jamovi. https:\/\/www.jamovi.org\/download.html. Accessed 13 July 2025."},{"key":"1185_CR26","unstructured":"Leaflet \u2014 an. open-source JavaScript library for interactive maps. https:\/\/leafletjs.com\/index.html. Accessed 27 Oct 2025."},{"key":"1185_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/trstmh\/trae136","volume":"119","author":"B Biswas","year":"2025","unstructured":"Biswas B, Gupta P, Jahnavi G, Ranjan N, Patra SR, Varshney S. Mass drug administration coverage evaluation for lymphatic filariasis in selected endemic districts of Jharkhand, India. Trans R Soc Trop Med Hyg. 2025;119:498\u2013505. https:\/\/doi.org\/10.1093\/trstmh\/trae136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"e0011588","DOI":"10.1371\/journal.pntd.0011588","volume":"17","author":"RJ Dinesh","year":"2023","unstructured":"Dinesh RJ, Srividya A, Subramanian S, Krishnamoorthy K, Sabesan S, Raghorte MC, et al. Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India. PLoS Negl Trop Dis. 2023;17:e0011588. https:\/\/doi.org\/10.1371\/journal.pntd.0011588.","journal-title":"PLoS Negl Trop Dis"},{"key":"1185_CR29","doi-asserted-by":"publisher","first-page":"1297954","DOI":"10.3389\/fphar.2024.1297954","volume":"15","author":"P Ratna","year":"2024","unstructured":"Ratna P, Sinha A, Pati S, Sahoo PK. Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India. Front Pharmacol. 2024;15:1297954. https:\/\/doi.org\/10.3389\/fphar.2024.1297954.","journal-title":"Front Pharmacol"},{"key":"1185_CR30","doi-asserted-by":"publisher","DOI":"10.4103\/JVBD.JVBD_67_24","author":"PS Babu","year":"2024","unstructured":"Babu PS, Goud BN, Kambale SB. Outcome assessment of the implementation of mass drug administration against lymphatic Filariasis, in Kalaburagi (Gulbarga) district of Karnataka state: A cross sectional survey. J Vector Borne Dis. 2024. https:\/\/doi.org\/10.4103\/JVBD.JVBD_67_24.","journal-title":"J Vector Borne Dis"},{"key":"1185_CR31","doi-asserted-by":"publisher","DOI":"10.4103\/jvbd.jvbd_58_25","author":"I Saha","year":"2025","unstructured":"Saha I, Majumder J, Bagepally BS, Ray D, Das S, Kalita M, et al. Coverage and determinants of mass drug administration against lymphatic filariasis in Southeast Asian regional countries during the End-game strategy: A systematic review & Meta-analysis of published articles from January 2019 to March 2025. J Vector Borne Dis. 2025. https:\/\/doi.org\/10.4103\/jvbd.jvbd_58_25.","journal-title":"J Vector Borne Dis"},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/jvbd.jvbd_102_24","volume":"62","author":"S Paul","year":"2025","unstructured":"Paul S, Seth AK, Pawar N, Singh A, Shukla M, Nath B. Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar pradesh: are we on the track? J Vector Borne Dis. 2025;62:172\u201380. https:\/\/doi.org\/10.4103\/jvbd.jvbd_102_24.","journal-title":"J Vector Borne Dis"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2105\/AJPH.2012.300993","volume":"103","author":"AK Cohen","year":"2013","unstructured":"Cohen AK, Syme SL. Education: a missed opportunity for public health intervention. Am J Public Health. 2013;103:997\u20131001. https:\/\/doi.org\/10.2105\/AJPH.2012.300993.","journal-title":"Am J Public Health"},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cegh.2019.04.013","volume":"8","author":"P Kulkarni","year":"2020","unstructured":"Kulkarni P, Thomas JJ, Dowerah J, Narayana Murthy MR, Ravikumar K. Mass drug administration programme against lymphatic filariasis-an evaluation of coverage and compliance in a Northern Karnataka district, India. Clin Epidemiol Global Health. 2020;8:87\u201390. https:\/\/doi.org\/10.1016\/j.cegh.2019.04.013.","journal-title":"Clin Epidemiol Global Health"},{"key":"1185_CR35","unstructured":"Ending the neglect to attain the Sustainable Development Goals. A road map for neglected tropical diseases 2021\u20132030. https:\/\/www.who.int\/publications\/i\/item\/9789240010352. Accessed 28 Oct 2025."},{"key":"1185_CR36","doi-asserted-by":"publisher","first-page":"e0009069","DOI":"10.1371\/journal.pntd.0009069","volume":"15","author":"P Jambulingam","year":"2021","unstructured":"Jambulingam P, Kuttiatt VS, Krishnamoorthy K, Subramanian S, Srividya A, Raju HKK, et al. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India. PLoS Negl Trop Dis. 2021;15:e0009069. https:\/\/doi.org\/10.1371\/journal.pntd.0009069.","journal-title":"PLoS Negl Trop Dis"},{"key":"1185_CR37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85552","author":"B Biswas","year":"2025","unstructured":"Biswas B, Pathak HN, Gupta P, Jahnavi G, Kalyani CV, Varshney S. Healthcare undergraduates\u2019 perception and practice regarding lymphatic filariasis and mass drug administration in a tertiary care facility in Eastern India. Cureus. 2025. https:\/\/doi.org\/10.7759\/cureus.85552.","journal-title":"Cureus"},{"key":"1185_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2049-9957-3-31","volume":"3","author":"MA Hussain","year":"2014","unstructured":"Hussain MA, Sitha AK, Swain S, Kadam S, Pati S. Mass drug administration for lymphatic filariasis elimination in a coastal state of india: a study on barriers to coverage and compliance. Infect Dis Poverty. 2014;3:31. https:\/\/doi.org\/10.1186\/2049-9957-3-31.","journal-title":"Infect Dis Poverty"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01185-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T02:03:04Z","timestamp":1768356184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-025-01185-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01185-7","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was based on routine monitoring data collected during the Mass Drug Administration (MDA) Coverage Evaluation for Lymphatic Filariasis (LF), conducted under official government protocols. Ethical clearance for analysis and publication was subsequently granted by the Institutional Research Committee (IRC) and Institutional Ethics Committee (IEC) of AIIMS Deoghar, Jharkhand, India (Ref. No. 2023-159-EMP-03). All participants were informed about the purpose of the survey, and written informed consent was obtained prior to data collection. Strict confidentiality of participant information was maintained throughout, and all data were used exclusively for programmatic improvement and research. The study was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}